Biotricity, Inc. Common Stock
BTCY
BTCY was delisted on the 2nd of August, 2024.
29 hedge funds and large institutions have $2.05M invested in Biotricity, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
7% more funds holding
Funds holding: 27 → 29 (+2)
0.28% less ownership
Funds ownership: 5.38% → 5.1% (-0.28%)
61% less capital inflows, than outflows
Capital inflows: $87.3K | Capital outflows: $221K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$44.4K |
| 2 |
Jane Street
New York
|
+$18K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10K |
| 4 |
Tower Research Capital (TRC)
New York
|
+$6.13K |
| 5 |
SFCL
Strengthening Families & Communities LLC
Boston,
Massachusetts
|
+$3.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$201K |
| 2 |
BlackRock
New York
|
-$13.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.96K |
| 4 |
Citigroup
New York
|
-$1K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$28 |
BTCY Hedge Fund Activity: Q3 2022 in Review
29 of the 5,831 institutional investors tracked by Wall St. Rank reported a position in Biotricity, Inc. Common Stock (BTCY) for Q3 2022, worth a combined $2.05M — down 57% from $4.79M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BTCY positions and 2 closed out — a net gain of 2 holders — while 6 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $44.4K. The largest seller was Vanguard Group, cutting an estimated $201K.
- 29 institutional investors held Biotricity, Inc. Common Stock (BTCY) as of Q3 2022, up from 27 in Q2 2022.
- Funds reported $2.05M of Biotricity, Inc. Common Stock stock for Q3 2022, down 57% quarter-over-quarter.
- 4 funds opened new Biotricity, Inc. Common Stock positions in Q3 2022 and 2 closed out, a net change of +2 holders.
- The largest Biotricity, Inc. Common Stock buyer in Q3 2022 was Susquehanna International Group, an estimated $44.4K added.
- The largest Biotricity, Inc. Common Stock seller in Q3 2022 was Vanguard Group, an estimated $201K sold.
Based on aggregated 13F filings for Q3 2022.